MedTrace Logo

Global Management of Facial Rejuvenation With a New Range of Hyaluronic Acid Dermal Fillers

NCT01151436 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 77

Last updated 2021-03-10

Study results available
· View outcomes & findings →

Summary

The aim of this study is to assess performance and tolerance as well as investigator and subject satisfaction linked to the global management of facial rejuvenation with a new range of hyaluronic acid dermal fillers.

Conditions

  • Facial Wrinkles

Interventions

DEVICE

hyaluronic acid dermal fillers

1 injection per indication and 1 touch-up injection if necessary

Sponsors & Collaborators

  • Galderma R&D

    lead INDUSTRY

Principal Investigators

  • Philippe KESTEMONT · Investigational site Nice France

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-03-31
Primary Completion
2010-11-30
Completion
2011-02-28

Countries

  • France
  • Germany

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01151436 on ClinicalTrials.gov